雄性脱髮症(AGA) 市场规模、份额、趋势分析报告：按性别、治疗、最终用途、销售管道、细分市场预测，2024-2030 年

雄性脱髮症(AGA) 市场成长与趋势：

Grand View Research最新报告预测，到2030年，全球雄性脱髮症（AGA）市场规模预计将达到47.6亿美元，2024年至2030年复合年增长率为8.45%。

雄性脱髮症（AGA）盛行率的增加是推动市场成长的关键因素之一。美国脱髮协会公布的资料显示，男性脱髮中95%以上是由雄性脱髮症（AGA）引起的。男性脱髮的发生率随着老龄化而增加。根据国际毛髮修復外科学会发表的报告，对于男性来说，40%的掉髮发生在35岁时，65%的掉髮发生在60岁时，70%的掉髮发生在80岁时，80%的掉髮发生在85岁时。就会出现脱髮的情况。

此外，市场成长归因于技术进步，包括引入低强度雷射治疗以促进头髮生长。同样，多雷射梳和头髮按摩器或刷子的推出也推动了市场的发展。例如，Lifemax 红外线髮刷、Follinex 按摩梳、Hairmax 雷射梳是市场上一些技术先进的产品。在大多数临床环境中，采用非剥脱性雷射疗法和局部涂布的联合治疗来取得更好的效果。雷射设备产生的微小伤口创造了良好的创伤治疗环境，促进毛髮生长。

此外，癌症等慢性病盛行率的增加预计将为市场成长提供有利可图的机会。例如，根据 Globocan 的最新报告，2020 年全球癌症发生率估计为 19,288,916 人。为癌症治疗患者开出的某些药物也会导致掉髮。例如，化疗药物、放射线治疗、荷尔蒙疗法、免疫治疗等都有可能诱发脱髮、头髮稀疏。预计未来 20 年癌症发生率将增加约 70%，从而推动市场成长。

然而，雄性脱髮症（AGA）治疗的报销是该市场的主要挑战之一。大多数 AGA治疗方法，并非医疗必需的，因此通常不在保险承保范围内。 AGA 治疗的自付额通常包括经常看医生、处方药的自付额以及手术的共同保险。脱髮症不是一种危及生命的疾病，因此其报销情况很复杂。例如，Aetna Inc. 的脱髮症政策规定，针对轻度病症的药物与针对严重病症的药物不同。此外，落建（米诺地尔）不属于该计划的涵盖范围，因为它被视为一种实验性治疗。因此，缺乏治疗报销政策限制了市场的成长。

雄性脱髮症(AGA) 市场报告亮点

• 由于雄性脱髮症(AGA) 治疗的采用率较高，男性细分市场在 2023 年占据市场主导地位。
• 2023年，医药板块占最大份额。产品核可数量的增加、製药公司投资的增加以及社会对采用药物治疗雄激素性脱髮症(AGA) 的态度的改变预计将在该细分市场的增长中发挥重要作用。
• 预计设备治疗领域在预测期内将以最快的复合年增长率成长。
• 由于消费者对处方药和雷射技术等最新治疗方法的认识不断提高，加上强大的产品平臺，皮肤科诊所最终用途细分市场在 2023 年占据了最大的收益占有率。
• 由于高疾病盛行率、消费者意识、积极的政府措施、技术进步和医疗保健基础设施的改善，北美在 2023 年占据了主要的销售份额。
• 2023年11月，Sun Pharma高级研究公司（SPARC）与约翰霍普金斯大学和捷克研究机构IOCB就SCD-153签订了独家授权合约，其中包括IOCB拥有的所有专利。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 雄性脱髮症(AGA) 市场：变数、趋势、范围

• 市场体系展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
• 雄性脱髮症(AGA) 市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析
• 雄性脱髮症(AGA) 市场：按地区分類的盛行率资料
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲 (MEA)

第四章雄性脱髮症（AGA）市场：性别估计和趋势分析

• 2023 年和 2030 年按性别分類的市场占有率
• 细分仪表板
• 按性别分類的全球雄性脱髮症(AGA) 市场展望
• 2018年至2030年市场规模、预测与趋势分析

第五章雄性脱髮症（AGA）市场：治疗估计与趋势分析

• 2023年及2030年治疗市场占有率
• 细分仪表板
• 全球雄性脱髮症(AGA) 治疗市场展望
• 2018年至2030年市场规模、预测与趋势分析

第六章雄性脱髮症（AGA）市场：最终用途估计和趋势分析

• 2023 年及 2030 年最终用途市场占有率
• 细分仪表板
• 按最终用途分類的全球雄性脱髮症(AGA) 市场展望
• 2018年至2030年市场规模、预测与趋势分析

第七章雄性脱髮症（AGA）市场：销售管道估计与趋势分析

• 2023年及2030年销售管道市场占有率
• 细分仪表板
• 按销售管道分類的全球雄性脱髮症(AGA) 市场展望
• 2018年至2030年市场规模、预测与趋势分析

第八章雄性脱髮症（AGA）市场：区域估计和趋势分析

• 2023 年及 2030 年区域市场占有率分析
• 区域市场仪表板
• 全球区域市场概述
• 2018-2030年市场规模及预测趋势分析
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 挪威
  • 瑞典
  • 丹麦
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 泰国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东/非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 科威特

第9章 竞争形势

• 主要市场参与企业的最新趋势和影响分析
• 公司/竞争对手分类
• 供应商形势
  • Johnson &Johnson Services, Inc.
  • Cipla, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Merck &Co., Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Lexington Intl., LLC
  • Freedom Laser Therapy, Inc.（iRESTORE Hair Growth System）
  • Curallux, LLC
  • Apira Science, Inc.（iGROW Laser）
  • Theradome, Inc.

Androgenetic Alopecia Market Growth & Trends:

The global androgenetic alopecia market size is anticipated to reach USD 4.76 billion by 2030 and is anticipated to expand at a CAGR of 8.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of androgenetic alopecia is one of the crucial factors driving the market growth. According to data published by the American Hair Loss Association, over 95% of hair loss in men is caused due to androgenetic alopecia. The occurrence of hair loss in men increases proportionately with age. On the basis of the report published by the International Society of Hair Restoration Surgery, in men, it is estimated that 40% of hair loss is encountered by the age of 35 years, 65% at 60 years, 70% at 80 years, and 80% at the age of 85 years.

Moreover, the market growth can be attributed to advancements in technology, including the introduction of a low-level laser therapy, which helps stimulate hair growth. Likewise, the introduction of several laser combs and hair massagers or brushes is also boosting the market. For instance, Lifemax Infrared Hairbrush, Follinex Massager Comb, and Hairmax Laser Comb are some of the technologically advanced products available in the market. Most clinical-based settings offer combination therapy of non-ablative laser treatment and topical application of medicinal products for better results. Microscopic injuries created by laser devices create a favorable wound-healing environment that triggers hair regrowth.

Furthermore, the increasing incidence of chronic diseases such as cancer is anticipated to offer lucrative opportunities for market growth. For instance, according to the latest report by Globocan, the incidence of cancer was estimated to be 19,288,916 in 2020 globally. Certain medications prescribed to patients for the treatment of cancer are also responsible for hair loss. For instance, chemotherapeutic agents, radiation therapy, hormone therapy, and immunotherapy are more likely to induce hair loss or hair thinning. Cancer incidence is expected to rise by about 70% over the next two decades, thus driving the market growth.

However, reimbursement coverage for androgenetic alopecia treatment is one of the major challenges in this market. Since most treatment modalities for AGA are considered cosmetic procedures and not medically essential ones, they are generally not covered under insurance. Out-of-pocket costs for AGA treatment usually include frequent doctor visits, prescription drug copays, and coinsurance for procedures. Alopecia has complex reimbursement positioning, as it is not a life-threatening disease. For instance, Aetna Inc.'s policy for alopecia states that drugs covered for mild conditions are different from those considered for more severe conditions. In addition, the scheme does not cover Rogaine (minoxidil) as it is considered an experimental therapy. Thus, lack of reimbursement policies for treatment is restraining the market growth.

Androgenetic Alopecia Market Report Highlights:

• The male segment dominated the market in 2023 due to the high adoption of androgenetic alopecia treatments
• The pharmaceuticals segment held the largest share in 2023. The increasing number of product approvals, rising investments by pharmaceutical companies, and shift in societal attitude toward adopting pharmaceutical drugs for the treatment of androgenetic alopecia are likely to play a prominent role in segment growth
• The devices treatment segment is expected to grow at the fastest CAGR over the forecast period
• The dermatology clinics end-use segment accounted for the largest revenue share in 2023 owing to increased consumer awareness regarding prescription medicines & modern treatments, such as laser technology, coupled with a strong product pipeline
• North America held a dominant revenue share in 2023 due to the high disease prevalence, consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
• In November 2023, Sun Pharma Advanced Research Company (SPARC) entered into an agreement with Johns Hopkins and the Czech research institute IOCB to exclusively license SCD-153, including all patents owned by IOCB

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Gender
  • 1.2.2. Treatment
  • 1.2.3. End Use
  • 1.2.4. Sales Channel
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in Asia Pacific
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Gender outlook
  • 2.2.2. Treatment outlook
  • 2.2.3. End use outlook
  • 2.2.4. Sales channel outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Androgenetic Alopecia Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of androgenic alopecia
    • 3.2.1.2. Technological advancements in androgenic alopecia
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of reimbursement policies for androgenic alopecia
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing prevalence of chronic diseases
• 3.3. Androgenetic Alopecia Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Androgenetic Alopecia Market: Prevalence Data, By Region
  • 3.4.1. North America
    • 3.4.1.1. U.S.
    • 3.4.1.2. Canada
  • 3.4.2. Europe
    • 3.4.2.1. UK
    • 3.4.2.2. Germany
    • 3.4.2.3. France
    • 3.4.2.4. Italy
    • 3.4.2.5. Spain
    • 3.4.2.6. Denmark
    • 3.4.2.7. Sweden
    • 3.4.2.8. Norway
  • 3.4.3. Asia Pacific
    • 3.4.3.1. Japan
    • 3.4.3.2. China
    • 3.4.3.3. India
    • 3.4.3.4. South Korea
    • 3.4.3.5. Australia
    • 3.4.3.6. Thailand
  • 3.4.4. Latin America
    • 3.4.4.1. Brazil
    • 3.4.4.2. Mexico
    • 3.4.4.3. Argentina
  • 3.4.5. Middle East and Africa (MEA)
    • 3.4.5.1. South Africa
    • 3.4.5.2. Saudi Arabia
    • 3.4.5.3. UAE
    • 3.4.5.4. Kuwait

Chapter 4. Androgenetic Alopecia Market: Gender Estimates & Trend Analysis

• 4.1. Gender Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Androgenetic Alopecia Market by Gender Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Male
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Female
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Androgenetic Alopecia Market: Treatment Estimates & Trend Analysis

• 5.1. Treatment Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Androgenetic Alopecia Market by Treatment Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Pharmaceuticals
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Devices
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Androgenetic Alopecia Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Androgenetic Alopecia Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Dermatology Clinics
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Homecare Settings
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Androgenetic Alopecia Market: Sales Channel Estimates & Trend Analysis

• 7.1. Sales Channel Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Androgenetic Alopecia Market by Sales Channel Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Prescription
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. OTC
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Androgenetic Alopecia Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.8.2. Mexico
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.8.3. Argentina
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework/ reimbursement structure
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. Johnson & Johnson Services, Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Cipla, Inc.
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Sun Pharmaceutical Industries Ltd.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Merck & Co., Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Dr. Reddy's Laboratories Ltd.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Aurobindo Pharma
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Lexington Intl., LLC
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Curallux, LLC
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Apira Science, Inc. (iGROW Laser)
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Theradome, Inc.
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 North America androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Table 3 North America androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 4 North America androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 5 North America androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 7 US androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 8 US androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 9 US androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 10 US androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 11 Canada androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 12 Canada androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 13 Canada androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 14 Canada androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 15 Europe androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Table 16 Europe androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 17 Europe androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 18 Europe androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 20 Germany androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 21 Germany androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 22 Germany androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 24 UK androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 25 UK androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 26 UK androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 27 UK androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 28 France androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 29 France androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 30 France androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 31 France androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 32 Italy androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 33 Italy androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 34 Italy androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 35 Italy androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 36 Spain androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 37 Spain androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 38 Spain androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 39 Spain androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 40 Denmark androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 41 Denmark androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 42 Denmark androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 43 Denmark androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 44 Sweden androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 45 Sweden androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 46 Sweden androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 47 Sweden androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 48 Norway androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 49 Norway androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 50 Norway androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 51 Norway androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Table 53 Asia Pacific androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 57 China androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 58 China androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 59 China androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 60 China androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 61 Japan androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 62 Japan androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 63 Japan androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 64 Japan androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 65 India androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 66 India androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 67 India androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 68 India androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 69 South Korea androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 70 South Korea androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 71 South Korea androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 72 South Korea androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 73 Australia androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 74 Australia androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 75 Australia androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 76 Australia androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 77 Thailand androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 78 Thailand androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 79 Thailand androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 80 Thailand androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 81 Latin America androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Table 82 Latin America androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 83 Latin America androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 84 Latin America androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 85 Latin America androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 86 Brazil androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 87 Brazil androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 88 Brazil androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 89 Brazil androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 90 Mexico androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 91 Mexico androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 92 Mexico androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 93 Mexico androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 94 Argentina androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 95 Argentina androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 96 Argentina androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 97 Argentina androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 98 MEA androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Table 99 MEA androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 100 MEA androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 101 MEA androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 102 MEA androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 103 South Africa androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 104 South Africa androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 105 South Africa androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 106 South Africa androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 111 UAE androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 112 UAE androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 113 UAE androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 114 UAE androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 115 Kuwait androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 116 Kuwait androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 117 Kuwait androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
• Table 118 Kuwait androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Androgenetic alopecia market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Value chain based sizing & forecasting
• Fig. 6 QFD modelling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Treatment and end-use segment snapshot
• Fig. 10 Sales channel and gender segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Market dynamics
• Fig. 13 Prevalence of rheumatoid arthritis in 2022, by WHO regions
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Androgenetic alopecia market: Gender outlook and key takeaways
• Fig. 17 Androgenetic alopecia market: Gender movement analysis
• Fig. 18 Male market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Female market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Androgenetic alopecia market: Treatment outlook and key takeaways
• Fig. 21 Androgenetic alopecia market: Treatment movement analysis
• Fig. 22 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Androgenetic alopecia market: End-use outlook and key takeaways
• Fig. 25 Androgenetic alopecia market: End-use movement analysis
• Fig. 26 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Homecare settings market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Androgenetic alopecia market: Sales channels outlook and key takeaways
• Fig. 29 Androgenetic alopecia market: Sales channels movement analysis
• Fig. 30 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 OTC market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Androgenetic alopecia market revenue, by region, 2023 & 2030 (USD Million)
• Fig. 33 Regional marketplace: Key takeaways (1/2)
• Fig. 34 Regional marketplace: Key takeaways (2/2)
• Fig. 35 North America androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 36 Key country dynamics
• Fig. 37 U.S. androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 38 Key country dynamics
• Fig. 39 Canada androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 40 Europe androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 41 Key country dynamics
• Fig. 42 UK androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 43 Key country dynamics
• Fig. 44 Germany androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 45 Key country dynamics
• Fig. 46 France androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 47 Key country dynamics
• Fig. 48 Spain androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 49 Key country dynamics
• Fig. 50 Italy androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 51 Key country dynamics
• Fig. 52 Denmark androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 53 Key country dynamics
• Fig. 54 Sweden androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 55 Key country dynamics
• Fig. 56 Norway androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 57 Rest of Europe androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
• Fig. 58 Asia Pacific androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 59 Key country dynamics
• Fig. 60 Reimbursement scenario
• Fig. 61 Japan androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 62 Key country dynamics
• Fig. 63 Regulatory framework
• Fig. 64 Reimbursement scenario
• Fig. 65 China androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 66 Key country dynamics
• Fig. 67 Reimbursement scenario
• Fig. 68 India androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 69 Key country dynamics
• Fig. 70 Australia androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 71 Key country dynamics
• Fig. 72 South Korea androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 73 Key country dynamics
• Fig. 74 Thailand androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 75 Key country dynamics
• Fig. 76 Malaysia androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 77 Key country dynamics
• Fig. 78 Vietnam androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 79 Key country dynamics
• Fig. 80 Philippines androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 81 Rest of Asia Pacific androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
• Fig. 82 Latin America androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 83 Key country dynamics
• Fig. 84 Brazil regulation details
• Fig. 85 Reimbursement scenario
• Fig. 86 Brazil androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 87 Key country dynamics
• Fig. 88 Argentina pharmaceuticals registration details
• Fig. 89 Argentina androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
• Fig. 90 Key country dynamics
• Fig. 91 Regulatory framework
• Fig. 92 Reimbursement scenario
• Fig. 93 Mexico androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 94 Rest of Latin America androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
• Fig. 95 MEA androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 South Africa androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 98 Key country dynamics
• Fig. 99 Saudi Arabia androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 100 Key country dynamics
• Fig. 101 UAE androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 102 Key country dynamics
• Fig. 103 Kuwait androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 104 Key country dynamics
• Fig. 105 Turkey androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 106 Rest of MEA androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
• Fig. 108 Company market share analysis, 2023
• Fig. 109 Strategic framework